Objective: The aim was to elucidate the relation between norepinephrine (NE) release and intraneuronal NE kinetics in the ischemic region of the in vivo heart. Methods: Using dialysis technique in the heart of anesthetized cats, we sampled dialysate from the ischemic region during 120-min coronary occlusion and reperfusion. Dialysate NE and dihydroxyphenylglycol (DHPG) contents were measured as indexes of myocardial interstitial NE and DHPG levels. Results: Within 20 min of occlusion, interstitial NE levels increased while DHPG levels decreased. This NE increase was suppressed by v-conotoxin GVIA and enhanced by desipramine. These data suggest that axoplasmic NE levels increased by neuronal reuptake following exocytotic release, while intraneuronal DHPG production was suppressed due to the reduced monoamine oxidase activity. After 20 min of occlusion, interstitial NE levels increased markedly, accompanied by increased DHPG levels. This NE increase was suppressed by desipramine. These findings imply that NE mobilization from stored vesicles to axoplasma exceeded outward NE transport through uptake carrier in the amount of NE, and that a substantial increase in axoplasmic 1 NE levels compensated for the reduced monoamine oxidase activity. After reperfusion, interstitial NE levels rapidly decreased while DHPG levels increased further. Both responses in NE and DHPG were suppressed by desipramine, indicating the involvement of recovered neuronal reuptake function. Conclusions: In the ischemic region, intraneuronal DHPG production was affected by alterations in monoamine oxidase activity, NE mobilization from stored vesicles, and carrier-mediated NE transport. The involvement of these factors in intraneuronal NE kinetics varied with the time of occlusion and reperfusion.
Introduction
outward NE transport through uptake carrier, and in-1 traneuronal degradation (Fig. 1) . To better understand the In the isolated perfused rat heart, it has been demonischemia-induced NE release, it is important to know strated that myocardial ischemia evokes an excessive intraneuronal NE kinetics during myocardial ischemia. norepinephrine (NE) efflux from cardiac sympathetic nerve
To examine intraneuronal NE kinetics in the heart, the endings [1-5]. The outward NE transport through uptake measurement of dihydroxyphenylglycol (DHPG) product-1 carrier has been proposed as an important mechanism ion has been widely used. In the cardiac sympathetic nerve responsible for the ischemia-induced NE release [1, 5] .
endings, axoplasmic free NE is subjected to deamination Carrier-mediated NE efflux from axoplasma to the interstiby monoamine oxidase [7] and DHPG is exclusively tial space is associated with alterations in axoplasmic free produced [8] [9] [10] [11] . DHPG is a highly lipophilic metabolite NE levels [6] . The axoplasmic NE concentration is regthat penetrates the membrane of sympathetic nerve endings ulated by various factors such as vesicle transport into by diffusion [12] . Thus, extraneuronal DHPG levels indistored vesicles, leakage from stored vesicles, inward and cate the axoplasmic NE concentration and provide certain information about intraneuronal NE kinetics. In the in vivo heart, however, there has been no study simultaneously *Corresponding author. Tel.: 181-6-6833-5012; fax: 181-6-6872-8092.
E-mail address: takiyama@ri.ncvc.go.jp (T. Akiyama). Time for primary review 31 days. investigating NE release and DHPG production during core temperatures within the range of 36-388C. Heparin myocardial ischemia.
sodium (200 U / kg) was administered intravenously and Previously, using the dialysis technique in the in vivo then 100 U / kg was given every 2 h to prevent blood heart, we demonstrated that coronary occlusion evokes coagulation. massive NE release in the ischemic region [13] , and that
With the animal in the lateral position, the fifth or sixth carrier-mediated NE release is partly involved in this NE rib on the left side was partially removed to expose the release [14, 15] . Moreover, we have reported that dialysis heart. A small incision was made in the pericardium, and technique makes it possible to simultaneously monitor the dialysis probe was implanted in the region perfused by myocardial interstitial NE and DHPG levels [16] . Therethe left anterior descending coronary artery (LAD) of the fore, we consider it possible to elucidate the relation left ventricular wall. A snare was placed around LAD just between NE release and intraneuronal NE kinetics in the distal to the first diagonal branch, to act as the occluder for ischemic region of the in vivo heart. In the present study, later coronary occlusion. To ensure that the sampling area we applied dialysis technique to the heart of anesthetized was in the ischemic region, we examined the color and cats and investigated myocardial interstitial NE and DHPG motion of the ventricular wall during a brief occlusion and levels during coronary occlusion and reperfusion.
confirmed that the dialysis probe was correctly located. (Fig. 2) 
In vivo dialysis technique

Methods
Materials suitable for cardiac dialysis probe have been 2.1. Animal preparation described in detail elsewhere [16, 17] . Briefly, we designed a handmade long transverse dialysis probe. period was 4 min (1 sampling vol540 ml). Each sample 2.3.2. Protocol 2: v-conotoxin GVIA was collected in a microtube containing 4 ml of 0.1 N HCl
To examine the involvement of exocytotic NE release 21 21 to prevent amine oxidation. Two thirds of the dialysate triggered by Ca influx through N-type Ca channels in sample was used for the measurement of NE and the the ischemia-induced NE release, we locally administered 21 remaining one third for the measurement of DHPG. NE the voltage-dependent N-type Ca channel blocker vand DHPG assays were separately conducted using each conotoxin GVIA (10 mM) through a dialysis probe, and high-performance liquid chromatography with electroobserved the responses of dialysate NE and DHPG in the chemical detection as previously described [18, 19] .
ischemic region in seven cats. Dialysate NE and DHPG concentrations were used as indexes of myocardial interstitial NE and DHPG levels.
2.3.3. Protocol 3: desipramine Based on the results of our previous study [17] , we
To examine the involvement of NE transport through discarded the first 120 min of dialysate and commenced uptake carrier in the ischemia-induced NE release, we 1 the protocol 120 min after probe implantation. From the locally administered the inhibitor of uptake carrier de-1 length and the internal diameter of the polyethylene tube, sipramine (10 mM) through a dialysis probe, and observed we calculated a dead space of 7.9 ml between the dialysis the responses of dialysate NE and DHPG in the ischemic fiber and sample tube. We took account of this space at the region in six cats. start of each dialysate sampling.
At the end of the experiment the cats were sacrificed with pentobarbital sodium, and the implant sites were 2.3. Experimental protocols examined. The dialysis probes had been implanted in the middle layer of the myocardium of the left ventricular After control sampling, we occluded LAD and sampled wall; no bleeding was found macroscopically. dialysate from the ischemic region during 120-min of coronary occlusion and reperfusion.
2.4. Statistical methods 2.3.1. Protocol 1: vehicle First to examine the influence of coronary occlusion and First, we observed the time course of dialysate NE and reperfusion, we analyzed the timecourse of heart rate, DHPG concentrations in the ischemic region in six cats. At mean arterial pressure and dialysate NE and DHPG in the 60 min after reperfusion, we locally administered tyramine vehicle group by using one-way analysis variance with (NE-releasing sympathomimetic amine, 60 mM) through a repeated measures. Second to examine the effect of pharmacological agents, we analyzed the differences in nificantly increased within 20 min of coronary occlusion. heart rate, mean arterial pressure, and dialysate NE and After 20 min of occlusion, the dialysate NE concentration DHPG at each time among three groups by using one-way markedly increased and reached 49086790 pg / ml at 60 analysis variance. When a statistical significance was min of occlusion. This NE level was maintained up to the detected, the Newman-Keuls test was applied [20] .
reperfusion. After reperfusion, the dialysate NE concenStatistical significance was defined as P,0.05. Values are tration rapidly decreased. presented as means6S.E.
The control dialysate DHPG concentration was 163611 pg / ml. The dialysate DHPG concentration slightly but significantly continued to decrease within 20 min of 3. Results occlusion and reached 121621 pg / ml at 20 min of occlusion. After 20 min of occlusion, the dialysate DHPG 3.1. Heart rate and mean arterial pressure concentration continued to increase and reached 421674 pg / ml at 120 min of occlusion. After reperfusion, the In protocol 1, heart rate significantly decreased from dialysate DHPG concentration further increased to 184613 in control to 143612 beats / min at 10 min of 8696167 pg / ml. coronary occlusion. During occlusion, heart rate gradually At 60 min after reperfusion, the dialysate NE conrecovered and reached 164610 beats / min at 120 min of centration was significantly increased by tyramine (from occlusion. After reperfusion heart rate significantly de-7966684 to 458461153 pg / ml). The dialysate DHPG creased to 139612 beats / min. Mean arterial pressure concentration was slightly increased by tyramine, but this significantly decreased from 11865 in control to 9766 increase was not significant. mmHg at 10 min of occlusion and maintained this level up to the reperfusion. After reperfusion, mean arterial pressure 3.2.2. Protocol 2: v-conotoxin GVIA (Figs. 4 and 5) significantly decreased to 8464 mmHg. In protocol 2 and
The control dialysate NE concentration was 1161 pg/ 3, local administration of pharmacological agents did not ml, which was significantly lower than that in the vehicle influence the responses of heart rate or mean arterial group. v-Conotoxin significantly suppressed the increase pressure.
in the dialysate NE concentration within 20 min of coronary occlusion. But after 20 min of occlusion, the 3.2. Dialysate NE and DHPG concentrations in the dialysate NE concentration markedly increased and the ischemic region dialysate NE concentration was almost the same as that in the vehicle group. 3.2.1. Protocol 1: vehicle (Fig. 3) The dialysate DHPG concentration in control was The control dialysate NE concentration was 1763 pg / 145613 pg / ml. This mean value was 89% of that in ml. The dialysate NE concentration gradually and sigvehicle. The dialysate DHPG concentration decreased within 20 min of occlusion and increased after 20 min of pg / ml, which was about five times that in the vehicle occlusion. After reperfusion, the dialysate DHPG congroup. The dialysate NE concentration was higher than centration increased further. During occlusion and reperfuthat in the vehicle group within 20 min of coronary sion, there were no significant differences in the dialysate occlusion. But desipramine significantly suppressed the DHPG response between protocols 1 and 2.
increase in the dialysate NE concentration at 40 min of occlusion. Compared with the data in protocol 1, the 3.2.3. Protocol 3: desipramine (Figs. 4 and 5) dialysate NE concentration was suppressed by 54% at 40 The control dialysate NE concentration was 96616 min of occlusion and by 38% at 60 min of occlusion. The In contrast to the early phase of ischemia, myocardial dialysate DHPG concentration was significantly suppressed interstitial DHPG levels began to increase after 20 min of after 40 min of occlusion and reperfusion.
occlusion. This enhancement of DHPG production indicates that monoamine oxidase activity dose not vanish. A substantial increase in axoplasmic free NE provides more substrate to monoamine oxidase, which compensates for 4. Discussion the reduction in monoamine oxidase activity [26] . Therefore, we consider axoplasmic NE levels to be substantially Using dialysis technique in the in vivo heart, we high in this phase. Intraneuronal degradation and outward observed myocardial interstitial NE and DHPG levels in NE transport through uptake carrier could contribute to 1 the ischemic region during coronary occlusion and reperfuthe decrease in axoplasmic NE levels. Our DHPG data sion. According to the responses of DHPG production to indicate that net leakage from stored vesicles to axoplasma the interventions tested, we divided the ischemic period exceeds intraneuronal degradation and outward NE transinto two phases.
port through uptake carrier in the amount of NE.
1
Desipramine inhibited the carrier-mediated outward 4.1. Within 20 min of coronary occlusion transport of axoplasmic NE at 40 min of occlusion. Therefore one would expect that desipramine should Myocardial interstitial NE levels gradually and sigfurther raise axoplasmic NE levels and enhance DHPG nificantly increased within 20 min of occlusion. The Nproduction. In the present study, however, desipramine 21 type Ca channel blocker v-conotoxin GVIA signifisignificantly suppressed the increase in myocardial intersticantly suppressed this increase. Thus, this increase could tial DHPG levels during occlusion. This result is in line 21 be mainly due to exocytotic NE release triggered by Ca with earlier in vitro studies [3, 5] and suggests that increase 21 influx through N-type Ca channels [21, 22] . Desipramine in axoplasmic NE levels during ischemia is suppressed by evoked the increase in myocardial interstitial NE levels in desipramine. But suppression by desipramine can not be this phase. This increase could be due to the inhibition of explained by inhibitory action on uptake carrier. De-1 inward NE transport through uptake carrier [23] . Theresipramine might have an additional action in reducing the 1 fore, we consider the inward NE transport, which is the net leakage of NE from storage vesicles [3, 5] . normal transport of uptake carrier, to remain active in this Neither v-conotoxin GVIA nor desipramine suppressed 1 phase. the increase in myocardial interstitial NE after 80 min of Myocardial interstitial DHPG levels slightly but sigocclusion. Desipramine continued to suppress DHPG nificantly decreased within 20 min of occlusion. This production after 80 min of occlusion. These results suggest indicates that DHPG production is suppressed in this another mechanism for NE release insensitive to vphase. When exocytotic NE release is activated under the conotoxin GVIA and desipramine, which may not be condition of intact reuptake function, inward NE transport associated with any alteration in axoplasmic NE levels. through uptake carrier raises axoplasmic NE levels and Recently, several groups have reported other mechanisms 1 DHPG production is enhanced [11, 24] . Our NE data for NE release during ischemia, including exocytotic 21 21 suggest that neuronal reuptake and exocytotic release release independent of Ca influx through N-type Ca remain active in this phase. Therefore, it could be difficult channel [15, 27, 28] . These mechanisms may be involved in to interpret the suppressed DHPG production as an altera-NE release in the late phase of ischemia. tion in axoplasmic NE levels. Monoamine oxidase, the enzyme involved in the formation of DHPG, is an oxygen-4.3. After reperfusion requiring enzyme [25] . The decrease in DHPG production may be explained by the reduction in monoamine oxidase Myocardial interstitial NE levels rapidly decreased after activity rather than decrease in axoplasmic NE as a reperfusion. Washout of retained NE from the interstitial substrate.
space may contribute to this decrease after reperfusion. In the presence of desipramine, however, myocardial interstiter pharmacological agents in the in vivo cardiac ischemic tial NE levels further increased after reperfusion. This region. Our in vivo findings of NE release were compatible result indicates that uptake carrier resumes normal transwith earlier in vitro studies using isolated perfused heart. 1 port function after reperfusion, and that the inward NE But findings of DHPG production highlighted the comtransport through uptake carrier is largely involved in the plexity in the mechanisms responsible for NE release 1 decrease in interstitial NE levels. during ischemia. Myocardial interstitial DHPG levels further increased after reperfusion. This enhancement of DHPG production may result from the recovery of monoamine oxidase Acknowledgements activity by reoxygenation. Desipramine significantly suppressed this increase in myocardial interstitial DHPG This study was supported by grants in aid for scientific levels after reperfusion. This finding indicates that inward research from the Ministry of Education, Science, and NE transport after reperfusion raises axoplasmic NE levels Culture of Japan and by a grant from the Technology and enhances DHPG production.
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